Bioqual EBITDA 2010-2024 | BIOQ
Bioqual ebitda from 2010 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
Bioqual Annual EBITDA
(Millions of US $) |
| 2024 |
$6 |
| 2023 |
$7 |
| 2022 |
$15 |
| 2021 |
$13 |
| 2020 |
$5 |
| 2019 |
$4 |
| 2018 |
$6 |
| 2017 |
$37 |
| 2016 |
$33 |
| 2015 |
$29 |
| 2013 |
$20 |
| 2012 |
$23 |
| 2011 |
$23 |
| 2010 |
$24 |
| 2009 |
$28 |
Bioqual Quarterly EBITDA
(Millions of US $) |
| 2024-08-31 |
$0 |
| 2024-05-31 |
$2 |
| 2024-02-29 |
$1 |
| 2023-11-30 |
$0 |
| 2023-08-31 |
$3 |
| 2023-05-31 |
$3 |
| 2023-02-28 |
$-1 |
| 2022-11-30 |
$5 |
| 2022-08-31 |
$-0 |
| 2022-05-31 |
$3 |
| 2022-02-28 |
$2 |
| 2021-11-30 |
$6 |
| 2021-08-31 |
$3 |
| 2021-05-31 |
$4 |
| 2021-02-28 |
$2 |
| 2020-11-30 |
$3 |
| 2020-08-31 |
$4 |
| 2020-05-31 |
$-2 |
| 2020-02-29 |
$2 |
| 2019-11-30 |
$2 |
| 2019-08-31 |
$3 |
| 2019-05-31 |
$12 |
| 2019-02-28 |
$1 |
| 2018-11-30 |
$1 |
| 2018-08-31 |
$10 |
| 2018-05-31 |
$10 |
| 2018-02-28 |
$8 |
| 2017-11-30 |
$9 |
| 2017-08-31 |
$9 |
| 2017-05-31 |
$9 |
| 2017-02-28 |
$9 |
| 2016-11-30 |
$9 |
| 2016-08-31 |
$9 |
| 2016-05-31 |
$10 |
| 2016-02-29 |
$9 |
| 2015-11-30 |
$8 |
| 2015-08-31 |
$7 |
| 2015-05-31 |
$7 |
| 2015-02-28 |
$7 |
| 2014-08-31 |
$7 |
| 2014-05-31 |
$7 |
| 2013-11-30 |
$5 |
| 2013-08-31 |
$5 |
| 2013-05-31 |
$5 |
| 2012-05-31 |
$5 |
| 2012-02-29 |
$6 |
| 2011-11-30 |
$6 |
| 2011-08-31 |
$6 |
| 2011-05-31 |
$6 |
| 2011-02-28 |
$6 |
| 2010-11-30 |
$6 |
| 2010-08-31 |
$5 |
| 2010-05-31 |
$18 |
| 2010-02-28 |
$6 |
| 2009-11-30 |
$6 |
| 2009-08-31 |
$6 |
| 2009-05-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Outpatient & Home Care |
$0.059B |
$0.059B |
|
BIOQUAL, Inc., formerly Diagnon Corporation, develops, produces and sells diagnostic test kits incorporating monoclonal antibodies to diagnose certain anemias, infections, and parasitic diseases.
|
